| |
 |
|
|
Inventor: Tamura; Yoshinori
Address: Osaka, JP
No. of patents: 5
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 6949566 |
Thiazole and oxazole derivatives |
September 27, 2005 |
| A compound of the formula (I): ##STR1## wherein R.sup.1 is hydroxy and the like; R.sup.2 is optionally substituted lower alkyl and the like; R.sup.3 is hydrogen atom and the like; R.sup.4 is optionally substituted arylene and the like; R.sup.5 is a group represented by the formula: |
| 6897237 |
MMP-12 inhibitors |
May 24, 2005 |
| A compound of the formula (I): ##STR1##wherein R.sup.1 is hydroxy and the like; R.sup.2 is optionally substituted lower alkyl and the like; R.sup.3 is hydrogen atom and the like; R.sup.4 is optionally substituted arylene and the like; R.sup.5 is --C.ident.C-- and the like; R.sup.6 is |
| 6878739 |
Composition for treating or preventing glomerulopathy |
April 12, 2005 |
| A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): ##STR1##wherein, for example, R.sup.1 and R.sup.2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R.sup.3 is 1,4-phe |
| 6495578 |
Sulfonamide derivatives having oxadiazole rings |
December 17, 2002 |
| Sulfonamide derivatives having a matrix metalloprotease inhibiting effect, which are compounds represented by general formula (I), optical isomers of the same, pharmaceutically acceptable salts of both, or solvates of them: ##STR1##wherein R.sup.1 and R.sup.2 are each independently hydro |
| 6423729 |
Therapeutic or prophylactic agent for glomerulopathy |
July 23, 2002 |
| A composition for treating or preventing glomerulopathy which contains a compound of the formula (I): ##STR1## wherein, for example, R.sup.1 and R.sup.2 are each independently hydrogen atom, optionally substituted lower alkyl, optionally substituted aralkyl, etc.; R.sup.3 is 1, |
|
|
|
